Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Sinopharm
Biotech
Texas biotech’s COVID booster takes on competitors in phase 3
Vaxxinity’s next-gen COVID-19 booster candidate has hit its safety targets in a head-to-head phase 3 trial.
Gabrielle Masson
Dec 2, 2022 11:00am
Sinopharm mulls $1B buy for DNA maker BBI Life Sciences: report
Jul 8, 2022 10:49am
Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up
Jan 15, 2021 9:05am
Chinese biotech Sinovac sees 78% COVID-19 vaccine efficacy
Jan 8, 2021 7:32am
China's Sinopharm sees 79% COVID-19 vaccine efficacy
Dec 30, 2020 9:25am
Sinopharm shares phase 2 data on inactivated COVID-19 vaccine
Aug 14, 2020 6:54am